| AA-LANSOPRAZOLE-AMOXICILLIN-CLARITHROMYCIN (500 MG)AA Pharma Inc. · Status since Oct 2022 | 02470780 | Marketed | AA Pharma Inc. | Oct 2022 |
| AG-AMOXI CLAV (500 MG)Angita Pharma Inc. · Status since Aug 2022 | 02510634 | Marketed | Angita Pharma Inc. | Aug 2022 |
| AG-AMOXI CLAV (875 MG)Angita Pharma Inc. · Status since Dec 2021 | 02510642 | Marketed | Angita Pharma Inc. | Dec 2021 |
| AG-AMOXICILLIN (500 MG)Angita Pharma Inc. · Status since Sep 2018 | 02477726 | Marketed | Angita Pharma Inc. | Sep 2018 |
| AG-AMOXICILLIN (250 MG)Angita Pharma Inc. · Status since Mar 2024 | 02537451 | Marketed | Angita Pharma Inc. | Mar 2024 |
| AMOXICILLIN (250 MG)Sanis Health Inc. · Status since Oct 2013 | 02352753 | Marketed | Sanis Health Inc. | Oct 2013 |
| AMOXICILLIN (250 MG)Sanis Health Inc. · Status since Oct 2013 | 02352788 | Marketed | Sanis Health Inc. | Oct 2013 |
| AMOXICILLIN (500 MG)Sivem Pharmaceuticals Ulc · Status since Oct 2020 | 02401509 | Marketed | Sivem Pharmaceuticals Ulc | Oct 2020 |
| AMOXICILLIN (250 MG)Sivem Pharmaceuticals Ulc · Status since Feb 2013 | 02401541 | Marketed | Sivem Pharmaceuticals Ulc | Feb 2013 |
| AMOXICILLIN CAPSULES BP (250 MG)Sanis Health Inc. · Status since Nov 2022 | 02525348 | Marketed | Sanis Health Inc. | Nov 2022 |
| AMOXICILLIN CAPSULES BP (500 MG)Sanis Health Inc. · Status since Nov 2022 | 02525356 | Marketed | Sanis Health Inc. | Nov 2022 |
| AMOXICILLIN SODIUM AND POTASSIUM CLAVULANATE FOR INJECTION (500 MG)Sandoz Canada Inc. · Status since Jul 2020 | 02495910 | Marketed | Sandoz Canada Inc. | Jul 2020 |
| AMOXICILLIN SODIUM AND POTASSIUM CLAVULANATE FOR INJECTION (1000 MG)Sandoz Canada Inc. · Status since Jul 2020 | 02495929 | Marketed | Sandoz Canada Inc. | Jul 2020 |
| AMOXICILLIN SODIUM AND POTASSIUM CLAVULANATE FOR INJECTION (2000 MG)Sandoz Canada Inc. · Status since Jul 2020 | 02495937 | Marketed | Sandoz Canada Inc. | Jul 2020 |
| AMOXICILLIN/CLAV (500 MG)Sanis Health Inc. · Status since Feb 2024 | 02536021 | Marketed | Sanis Health Inc. | Feb 2024 |
| AMOXICILLIN/CLAV (875 MG)Sanis Health Inc. · Status since Feb 2024 | 02536048 | Marketed | Sanis Health Inc. | Feb 2024 |
| AMOXIL (100 MG)Zoetis Canada Inc · Status since Sep 2016 | 02038293 | Marketed | Zoetis Canada Inc | Sep 2016 |
| APO-AMOXI (250 MG)Apotex Inc. · Status since Oct 2019 | 00628115 | Marketed | Apotex Inc. | Oct 2019 |
| APO-AMOXI (500 MG)Apotex Inc. · Status since Oct 2019 | 00628123 | Marketed | Apotex Inc. | Oct 2019 |
| APO-AMOXI (125 MG)Apotex Inc. · Status since Jun 2020 | 00628131 | Marketed | Apotex Inc. | Jun 2020 |
| APO-AMOXI (250 MG)Apotex Inc. · Status since Jun 2020 | 00628158 | Marketed | Apotex Inc. | Jun 2020 |
| APO-AMOXI CLAV (250 MG)Apotex Inc. · Status since Feb 2020 | 02243350 | Marketed | Apotex Inc. | Feb 2020 |
| APO-AMOXI CLAV (500 MG)Apotex Inc. · Status since Feb 2020 | 02243351 | Marketed | Apotex Inc. | Feb 2020 |
| APO-AMOXI CLAV (875 MG)Apotex Inc. · Status since Jul 2019 | 02245623 | Marketed | Apotex Inc. | Jul 2019 |
| AURO-AMOXICILLIN (250 MG)Auro Pharma Inc. · Status since Jul 2012 | 02388073 | Marketed | Auro Pharma Inc. | Jul 2012 |
| AURO-AMOXICILLIN (500 MG)Auro Pharma Inc. · Status since Jul 2012 | 02388081 | Marketed | Auro Pharma Inc. | Jul 2012 |
| AURO-AMOXICILLIN (125 MG)Auro Pharma Inc. · Status since Oct 2021 | 02458586 | Marketed | Auro Pharma Inc. | Oct 2021 |
| AURO-AMOXICILLIN (250 MG)Auro Pharma Inc. · Status since Oct 2021 | 02458594 | Marketed | Auro Pharma Inc. | Oct 2021 |
| AURO-AMOXICLAV (250 MG)Auro Pharma Inc. · Status since Mar 2022 | 02471671 | Marketed | Auro Pharma Inc. | Mar 2022 |
| AURO-AMOXICLAV (500 MG)Auro Pharma Inc. · Status since Mar 2022 | 02471698 | Marketed | Auro Pharma Inc. | Mar 2022 |
| AURO-AMOXICLAV (875 MG)Auro Pharma Inc. · Status since Mar 2022 | 02471701 | Marketed | Auro Pharma Inc. | Mar 2022 |
| CLAVAMOX (50 MG)Zoetis Canada Inc · Status since Oct 2019 | 02489473 | Marketed | Zoetis Canada Inc | Oct 2019 |
| CLAVAMOX (100 MG)Zoetis Canada Inc · Status since Oct 2019 | 02489481 | Marketed | Zoetis Canada Inc | Oct 2019 |
| CLAVAMOX (200 MG)Zoetis Canada Inc · Status since Oct 2019 | 02489503 | Marketed | Zoetis Canada Inc | Oct 2019 |
| CLAVAMOX (300 MG)Zoetis Canada Inc · Status since Oct 2019 | 02489511 | Marketed | Zoetis Canada Inc | Oct 2019 |
| CLAVAMOX DROPS (50 MG)Zoetis Canada Inc · Status since Oct 2016 | 02027879 | Marketed | Zoetis Canada Inc | Oct 2016 |
| CLAVASEPTIN 250 MG (200 MG)Vetoquinol N A Inc · Status since Aug 2014 | 02316919 | Marketed | Vetoquinol N A Inc | Aug 2014 |
| CLAVASEPTIN 50 MG (40 MG)Vetoquinol N A Inc · Status since Aug 2014 | 02316900 | Marketed | Vetoquinol N A Inc | Aug 2014 |
| CLAVASEPTIN 500 MG (400 MG)Vetoquinol N A Inc · Status since Aug 2014 | 02316927 | Marketed | Vetoquinol N A Inc | Aug 2014 |
| CLAVASEPTIN 62.5MG (50 MG)Vetoquinol N A Inc · Status since Aug 2014 | 02396556 | Marketed | Vetoquinol N A Inc | Aug 2014 |
| CLAVASEPTIN 750 MG (600 MG)Vetoquinol N A Inc · Status since Jun 2023 | 02535831 | Marketed | Vetoquinol N A Inc | Jun 2023 |
| CLAVULIN 125 F ORAL SUS (125 MG)Glaxosmithkline Inc · Status since Feb 2003 | 01916882 | Marketed | Glaxosmithkline Inc | Feb 2003 |
| CLAVULIN 200 (200 MG)Glaxosmithkline Inc · Status since Jan 2003 | 02238831 | Marketed | Glaxosmithkline Inc | Jan 2003 |
| CLAVULIN 250 F ORAL SUS (250 MG)Glaxosmithkline Inc · Status since Jan 2003 | 01916874 | Marketed | Glaxosmithkline Inc | Jan 2003 |
| CLAVULIN 400 (400 MG)Glaxosmithkline Inc · Status since Dec 2002 | 02238830 | Marketed | Glaxosmithkline Inc | Dec 2002 |
| JAMP AMOXI CLAV (250 MG)JAMP Pharma Corporation · Status since Dec 2021 | 02508249 | Marketed | JAMP Pharma Corporation | Dec 2021 |
| JAMP AMOXI CLAV (500 MG)JAMP Pharma Corporation · Status since Dec 2021 | 02508257 | Marketed | JAMP Pharma Corporation | Dec 2021 |
| JAMP AMOXI CLAV (875 MG)JAMP Pharma Corporation · Status since Dec 2021 | 02508265 | Marketed | JAMP Pharma Corporation | Dec 2021 |
| JAMP AMOXI CLAV SUSPENSION (250 MG)JAMP Pharma Corporation · Status since Jul 2024 | 02539438 | Marketed | JAMP Pharma Corporation | Jul 2024 |
| JAMP AMOXI CLAV SUSPENSION (400 MG)JAMP Pharma Corporation · Status since Jul 2024 | 02539446 | Marketed | JAMP Pharma Corporation | Jul 2024 |
| JAMP-AMOXICILLIN (250 MG)JAMP Pharma Corporation · Status since Dec 2015 | 02433060 | Marketed | JAMP Pharma Corporation | Dec 2015 |
| JAMP-AMOXICILLIN (500 MG)JAMP Pharma Corporation · Status since Dec 2015 | 02433079 | Marketed | JAMP Pharma Corporation | Dec 2015 |
| JAMP-AMOXICILLIN (125 MG)JAMP Pharma Corporation · Status since Apr 2023 | 02535793 | Marketed | JAMP Pharma Corporation | Apr 2023 |
| JAMP-AMOXICILLIN (250 MG)JAMP Pharma Corporation · Status since Apr 2023 | 02535815 | Marketed | JAMP Pharma Corporation | Apr 2023 |
| M-AMOXI CLAV (400 MG)Mantra Pharma Inc. · Status since Nov 2022 | 02530694 | Marketed | Mantra Pharma Inc. | Nov 2022 |
| M-AMOXI CLAV (250 MG)Mantra Pharma Inc. · Status since Feb 2024 | 02542226 | Marketed | Mantra Pharma Inc. | Feb 2024 |
| NOVAMOXIN (500 MG)Teva Canada Limited · Status since Jun 2013 | 00406716 | Marketed | Teva Canada Limited | Jun 2013 |
| NOVAMOXIN (250 MG)Teva Canada Limited · Status since Jun 2013 | 00406724 | Marketed | Teva Canada Limited | Jun 2013 |
| NOVAMOXIN (250 MG)Teva Canada Limited · Status since Jun 2013 | 00452130 | Marketed | Teva Canada Limited | Jun 2013 |
| NOVAMOXIN (250 MG)Teva Canada Limited · Status since Jun 2013 | 02036355 | Marketed | Teva Canada Limited | Jun 2013 |
| NOVAMOXIN (250 MG)Teva Canada Limited · Status since Jun 2013 | 01934163 | Marketed | Teva Canada Limited | Jun 2013 |
| NRA-AMOXICILLIN (500 MG)Nora Pharma Inc. · Status since May 2026 | 02561417 | Marketed | Nora Pharma Inc. | May 2026 |
| PRO-AMOX-250 (250 MG)Pro Doc Limitee · Status since Nov 2020 | 00644331 | Marketed | Pro Doc Limitee | Nov 2020 |
| PRO-AMOX-500 (500 MG)Pro Doc Limitee · Status since Jun 2020 | 00644315 | Marketed | Pro Doc Limitee | Jun 2020 |
| PRO-AMOXI CLAV (500 MG)Pro Doc Limitee · Status since Jul 2023 | 02536498 | Marketed | Pro Doc Limitee | Jul 2023 |
| PRO-AMOXI CLAV (875 MG)Pro Doc Limitee · Status since Jul 2023 | 02536501 | Marketed | Pro Doc Limitee | Jul 2023 |
| PRZ-AMOXICILLIN (250 MG)Pharmaris Canada Inc. · Status since Dec 2023 | 02532042 | Marketed | Pharmaris Canada Inc. | Dec 2023 |
| PRZ-AMOXICILLIN (500 MG)Pharmaris Canada Inc. · Status since Dec 2023 | 02532050 | Marketed | Pharmaris Canada Inc. | Dec 2023 |
| SANDOZ AMOXI-CLAV TABLET (500 MG)Sandoz Canada Inc. · Status since Mar 2019 | 02482576 | Marketed | Sandoz Canada Inc. | Mar 2019 |
| SANDOZ AMOXI-CLAV TABLET (875 MG)Sandoz Canada Inc. · Status since Mar 2019 | 02482584 | Marketed | Sandoz Canada Inc. | Mar 2019 |
| SANDOZ AMOXICILLIN (250 MG)Sandoz Canada Inc. · Status since Apr 2024 | 02495864 | Marketed | Sandoz Canada Inc. | Apr 2024 |
| AG-AMOXI CLAV (250 MG)Angita Pharma Inc. · Status since Jan 2021 | 02510626 | Approved | Angita Pharma Inc. | Jan 2021 |
| AG-AMOXI CLAV SUSPENSION (200 MG)Angita Pharma Inc. · Status since Aug 2023 | 02540649 | Approved | Angita Pharma Inc. | Aug 2023 |
| AG-AMOXI CLAV SUSPENSION (400 MG)Angita Pharma Inc. · Status since Aug 2023 | 02540657 | Approved | Angita Pharma Inc. | Aug 2023 |
| AG-AMOXI CLAV SUSPENSION (250 MG)Angita Pharma Inc. · Status since Aug 2023 | 02540665 | Approved | Angita Pharma Inc. | Aug 2023 |
| AG-AMOXICILLIN (250 MG)Angita Pharma Inc. · Status since Jul 2021 | 02477718 | Dormant | Angita Pharma Inc. | Jul 2021 |
| AMOXICILLIN (250 MG)Sanis Health Inc. · Status since Mar 2023 | 02352710 | Dormant | Sanis Health Inc. | Mar 2023 |
| AMOXICILLIN (500 MG)Sanis Health Inc. · Status since Nov 2023 | 02352729 | Dormant | Sanis Health Inc. | Nov 2023 |
| APO-AMOXI CLAV (400 MG)Apotex Inc. · Status since Aug 2017 | 02288559 | Dormant | Apotex Inc. | Aug 2017 |
| APO-AMOXI CLAV 250MG/62.5MG PER 5ML (250 MG)Apotex Inc. · Status since Aug 2017 | 02243987 | Dormant | Apotex Inc. | Aug 2017 |
| APO-AMOXICILLIN (250 MG)Apotex Inc. · Status since Apr 2021 | 02514648 | Approved | Apotex Inc. | Apr 2021 |
| APO-AMOXICILLIN (500 MG)Apotex Inc. · Status since Apr 2021 | 02514656 | Approved | Apotex Inc. | Apr 2021 |
| APO-AMOXICILLIN (125 MG)Apotex Inc. · Status since Apr 2021 | 02514664 | Approved | Apotex Inc. | Apr 2021 |
| APO-AMOXICILLIN (250 MG)Apotex Inc. · Status since Apr 2021 | 02514672 | Approved | Apotex Inc. | Apr 2021 |
| APO-AMOXICILLIN-CLAVULANATE (250 MG)Apotex Inc. · Status since May 2021 | 02515598 | Approved | Apotex Inc. | May 2021 |
| APO-AMOXICILLIN-CLAVULANATE (500 MG)Apotex Inc. · Status since May 2021 | 02515601 | Approved | Apotex Inc. | May 2021 |
| APO-AMOXICILLIN-CLAVULANATE (875 MG)Apotex Inc. · Status since May 2021 | 02515628 | Approved | Apotex Inc. | May 2021 |
| AVENTICLAV (50 MG)Norbrook Laboratories Ltd. · Status since Jul 2022 | 02394324 | Dormant | Norbrook Laboratories Ltd. | Jul 2022 |
| AVENTICLAV (100.0 MG)Norbrook Laboratories Ltd. · Status since Jul 2022 | 02394332 | Dormant | Norbrook Laboratories Ltd. | Jul 2022 |
| AVENTICLAV (200.0 MG)Norbrook Laboratories Ltd. · Status since Jul 2022 | 02394340 | Dormant | Norbrook Laboratories Ltd. | Jul 2022 |
| AVENTICLAV (300.0 MG)Norbrook Laboratories Ltd. · Status since Jul 2022 | 02394359 | Dormant | Norbrook Laboratories Ltd. | Jul 2022 |
| JAMP AMOXI CLAV SUSPENSION (200 MG)JAMP Pharma Corporation · Status since Aug 2026 | 02539411 | Dormant | JAMP Pharma Corporation | Aug 2026 |
| MINT-AMOXI/CLAV (250 MG)Mint Pharmaceuticals Inc · Status since Mar 2021 | 02513250 | Approved | Mint Pharmaceuticals Inc | Mar 2021 |
| MINT-AMOXI/CLAV (500 MG)Mint Pharmaceuticals Inc · Status since Mar 2021 | 02513269 | Approved | Mint Pharmaceuticals Inc | Mar 2021 |
| MINT-AMOXI/CLAV (875 MG)Mint Pharmaceuticals Inc · Status since Mar 2021 | 02513277 | Approved | Mint Pharmaceuticals Inc | Mar 2021 |
| MOXILEAN (AMOXICILLIN TABLETS 100MG) (100 MG)Bimeda-MTC Animal Health Inc. · Status since Jul 2018 | 00574910 | Dormant | Bimeda-MTC Animal Health Inc. | Jul 2018 |
| MOXILEAN (AMOXICILLIN TABLETS 400MG) (400 MG)Bimeda-MTC Animal Health Inc. · Status since Jul 2018 | 00632635 | Dormant | Bimeda-MTC Animal Health Inc. | Jul 2018 |
| MOXILEAN 50 SUS 50MG/ML (750 MG)Mtc Pharmaceuticals · Status since Jul 2018 | 00574929 | Dormant | Mtc Pharmaceuticals | Jul 2018 |
| NRA-AMOXICILLIN (250 MG)Nora Pharma Inc. · Status since Sep 2025 | 02561409 | Approved | Nora Pharma Inc. | Sep 2025 |
| PRO-AMOX-125 (125 MG)Pro Doc Limitee · Status since Oct 2019 | 02493381 | Approved | Pro Doc Limitee | Oct 2019 |
| PRO-AMOX-250 (250 MG)Pro Doc Limitee · Status since Sep 2019 | 02492210 | Approved | Pro Doc Limitee | Sep 2019 |
| PRO-AMOXI CLAV (250 MG)Pro Doc Limitee · Status since Mar 2023 | 02536471 | Approved | Pro Doc Limitee | Mar 2023 |
| SANDOZ AMOXICILLIN (125 MG)Sandoz Canada Inc. · Status since Jan 2020 | 02495856 | Approved | Sandoz Canada Inc. | Jan 2020 |
| AMOX 250 CAP 250MG (250 MG)Jaapharm Canada Inc. · Status since Apr 2002 | 00885886 | Cancelled Post Market | Jaapharm Canada Inc. | Apr 2002 |
| AMOX 500 CAP 500MG (500 MG)Jaapharm Canada Inc. · Status since Apr 2002 | 00885894 | Cancelled Post Market | Jaapharm Canada Inc. | Apr 2002 |
| AMOX S 125 SUS 125MG/5ML (125 MG)Jaapharm Canada Inc. · Status since Apr 2002 | 00885908 | Cancelled Post Market | Jaapharm Canada Inc. | Apr 2002 |
| AMOX S 250 SUS 250MG/5ML (250 MG)Jaapharm Canada Inc. · Status since Apr 2002 | 00885916 | Cancelled Post Market | Jaapharm Canada Inc. | Apr 2002 |
| AMOXI-CLAV (500 MG)Pro Doc Limitee · Status since Jan 2018 | 02326515 | Cancelled Post Market | Pro Doc Limitee | Jan 2018 |
| AMOXI-CLAV (875 MG)Pro Doc Limitee · Status since Apr 2018 | 02326523 | Cancelled Post Market | Pro Doc Limitee | Apr 2018 |
| AMOXICILLIN (500 MG)BGP Pharma ULC · Status since Apr 2023 | 02237154 | Cancelled Pre Market | BGP Pharma ULC | Apr 2023 |
| AMOXICILLIN (250 MG)Sanis Health Inc. · Status since Aug 2012 | 02352737 | Cancelled Post Market | Sanis Health Inc. | Aug 2012 |
| AMOXICILLIN (125 MG)Sanis Health Inc. · Status since Jul 2017 | 02352745 | Cancelled Post Market | Sanis Health Inc. | Jul 2017 |
| AMOXICILLIN (125 MG)Sanis Health Inc. · Status since Jul 2017 | 02352761 | Cancelled Post Market | Sanis Health Inc. | Jul 2017 |
| AMOXICILLIN (250 MG)Sivem Pharmaceuticals Ulc · Status since Jun 2018 | 02401495 | Cancelled Post Market | Sivem Pharmaceuticals Ulc | Jun 2018 |
| AMOXICILLIN (250 MG)JAMP Pharma Corporation · Status since May 2024 | 02434709 | Cancelled Pre Market | JAMP Pharma Corporation | May 2024 |
| AMOXICILLIN (500 MG)JAMP Pharma Corporation · Status since May 2024 | 02434717 | Cancelled Pre Market | JAMP Pharma Corporation | May 2024 |
| AMOXICILLIN CAPSULES 250 MG (250 MG)4349121 Canada Inc · Status since Jan 2024 | 02241826 | Cancelled (Unreturned Annual) | 4349121 Canada Inc | Jan 2024 |
| AMOXICILLIN CAPSULES 500 MG (500 MG)4349121 Canada Inc · Status since Jan 2024 | 02241827 | Cancelled (Unreturned Annual) | 4349121 Canada Inc | Jan 2024 |
| AMOXICILLIN CAPSULES BP (250 MG)Valesco Pharmaceuticals Inc · Status since Sep 2018 | 02319594 | Cancelled Pre Market | Valesco Pharmaceuticals Inc | Sep 2018 |
| AMOXICILLIN CAPSULES BP (500 MG)Valesco Pharmaceuticals Inc · Status since Sep 2018 | 02319608 | Cancelled Pre Market | Valesco Pharmaceuticals Inc | Sep 2018 |
| AMOXICILLIN FOR ORAL SUSPENSION 125MG/5ML (125 MG)4349121 Canada Inc · Status since Jan 2024 | 02243224 | Cancelled (Unreturned Annual) | 4349121 Canada Inc | Jan 2024 |
| AMOXICILLIN FOR ORAL SUSPENSION 250MG/5ML (250 MG)4349121 Canada Inc · Status since Jan 2024 | 02243225 | Cancelled (Unreturned Annual) | 4349121 Canada Inc | Jan 2024 |
| AMOXICILLIN GRANULES FOR ORAL SUSPENSION (125 MG)Sivem Pharmaceuticals Ulc · Status since Mar 2018 | 02401533 | Cancelled Pre Market | Sivem Pharmaceuticals Ulc | Mar 2018 |
| AMOXICILLIN SUGAR-REDUCED GRANULES FOR ORAL SUSPENSION (125 MG)Sivem Pharmaceuticals Ulc · Status since Mar 2018 | 02401568 | Cancelled Pre Market | Sivem Pharmaceuticals Ulc | Mar 2018 |
| AMOXICILLIN SUGAR-REDUCED GRANULES FOR ORAL SUSPENSION (250 MG)Sivem Pharmaceuticals Ulc · Status since Dec 2016 | 02401576 | Cancelled Post Market | Sivem Pharmaceuticals Ulc | Dec 2016 |
| AMOXICILLIN TAB 100MG (100 MG)P.V.U., Division Of Vétoquinol N.-A. Inc. · Status since Aug 2001 | 00795925 | Cancelled Post Market | P.V.U., Division Of Vétoquinol N.-A. Inc. | Aug 2001 |
| AMOXICILLIN TABLETS 100MG (100 MG)Vetoquinol N A Inc · Status since Apr 2014 | 02184613 | Cancelled Post Market | Vetoquinol N A Inc | Apr 2014 |
| AMOXIL (50 MG)Zoetis Canada Inc · Status since Jul 2022 | 02038307 | Cancelled Post Market | Zoetis Canada Inc | Jul 2022 |
| AMOXIL (200 MG)Zoetis Canada Inc · Status since Jul 2022 | 02038285 | Cancelled Post Market | Zoetis Canada Inc | Jul 2022 |
| AMOXIL (400 MG)Zoetis Canada Inc · Status since Jul 2022 | 02038277 | Cancelled Post Market | Zoetis Canada Inc | Jul 2022 |
| AMOXIL 125 ORAL SUSPENSION (25 MG)Ayerst Laboratories · Status since Aug 1997 | 00288500 | Cancelled Post Market | Ayerst Laboratories | Aug 1997 |
| AMOXIL 250 CAP (250 MG)Ayerst Laboratories · Status since Aug 1997 | 00288497 | Cancelled Post Market | Ayerst Laboratories | Aug 1997 |
| AMOXIL 250 ORAL SUSPENSION (50 MG)Ayerst Laboratories · Status since Aug 1997 | 00288519 | Cancelled Post Market | Ayerst Laboratories | Aug 1997 |
| AMOXIL CAP 500MG (500 MG)Ayerst Laboratories · Status since Sep 1996 | 00330531 | Cancelled Post Market | Ayerst Laboratories | Sep 1996 |
| AMOXIL CHEWABLE TAB 125MG (125 MG)Ayerst Laboratories · Status since Aug 2000 | 00714887 | Cancelled Post Market | Ayerst Laboratories | Aug 2000 |
| AMOXIL CHEWABLE TAB 250MG (250 MG)Ayerst Laboratories · Status since Aug 1997 | 00714895 | Cancelled Post Market | Ayerst Laboratories | Aug 1997 |
| AMOXIL CHEWABLE TABLETS 125MG (125 MG)Wyeth-Ayerst Canada Inc. · Status since Apr 2001 | 02041685 | Cancelled Post Market | Wyeth-Ayerst Canada Inc. | Apr 2001 |
| AMOXIL CHEWABLE TABLETS 250MG (250 MG)Wyeth-Ayerst Canada Inc. · Status since Apr 2001 | 02041286 | Cancelled Post Market | Wyeth-Ayerst Canada Inc. | Apr 2001 |
| AMOXIL PEDIATRIC DROPS PWS 50MG/ML (50 MG)Wyeth-Ayerst Canada Inc. · Status since Jan 1997 | 02041324 | Cancelled Post Market | Wyeth-Ayerst Canada Inc. | Jan 1997 |
| AMOXIL-125 PWS 125MG/5ML (125 MG)Wyeth-Ayerst Canada Inc. · Status since Sep 2001 | 02041316 | Cancelled Post Market | Wyeth-Ayerst Canada Inc. | Sep 2001 |
| AMOXIL-250 CAP 250MG (250 MG)Wyeth-Ayerst Canada Inc. · Status since Apr 2001 | 02041294 | Cancelled Post Market | Wyeth-Ayerst Canada Inc. | Apr 2001 |
| AMOXIL-250 PWS 250MG/5ML (250 MG)Wyeth-Ayerst Canada Inc. · Status since Dec 2001 | 02042592 | Cancelled Post Market | Wyeth-Ayerst Canada Inc. | Dec 2001 |
| AMOXIL-500 CAP 500MG (500 MG)Wyeth-Ayerst Canada Inc. · Status since Aug 2001 | 02041308 | Cancelled Post Market | Wyeth-Ayerst Canada Inc. | Aug 2001 |
| APO-AMOXI CLAV 125MG/31.25MG PER 5ML (125 MG)Apotex Inc. · Status since Apr 2020 | 02243986 | Cancelled Post Market | Apotex Inc. | Apr 2020 |
| APO-AMOXI SUGAR FREE (125 MG)Apotex Inc. · Status since Jul 2024 | 02230879 | Cancelled Post Market | Apotex Inc. | Jul 2024 |
| APO-AMOXI SUGAR FREE (250 MG)Apotex Inc. · Status since Jul 2024 | 02230880 | Cancelled Post Market | Apotex Inc. | Jul 2024 |
| BIOCLAV (50 MG)Novopharm Limited · Status since Jul 2018 | 02299380 | Cancelled Post Market | Novopharm Limited | Jul 2018 |
| BIOCLAV (100 MG)Novopharm Limited · Status since Jul 2018 | 02299399 | Cancelled Post Market | Novopharm Limited | Jul 2018 |
| BIOCLAV (200 MG)Novopharm Limited · Status since Jul 2018 | 02299402 | Cancelled Post Market | Novopharm Limited | Jul 2018 |
| BIOCLAV (300 MG)Novopharm Limited · Status since Jul 2018 | 02299410 | Cancelled Post Market | Novopharm Limited | Jul 2018 |
| CLAVAMOX (50 MG)Zoetis Canada Inc · Status since Jul 2022 | 02038323 | Cancelled Post Market | Zoetis Canada Inc | Jul 2022 |
| CLAVAMOX (300 MG)Zoetis Canada Inc · Status since Jul 2022 | 02038358 | Cancelled Post Market | Zoetis Canada Inc | Jul 2022 |
| CLAVAMOX (100 MG)Zoetis Canada Inc · Status since Jul 2022 | 02038331 | Cancelled Post Market | Zoetis Canada Inc | Jul 2022 |
| CLAVAMOX (200 MG)Zoetis Canada Inc · Status since Jul 2022 | 02038315 | Cancelled Post Market | Zoetis Canada Inc | Jul 2022 |
| CLAVULIN 250 TAB (250 MG)Glaxosmithkline Inc · Status since Aug 2007 | 01916866 | Cancelled Post Market | Glaxosmithkline Inc | Aug 2007 |
| CLAVULIN 500 F TAB (500 MG)Glaxosmithkline Inc · Status since Jan 2024 | 01916858 | Cancelled Post Market | Glaxosmithkline Inc | Jan 2024 |
| CLAVULIN 875 (875 MG)Glaxosmithkline Inc · Status since Jan 2024 | 02238829 | Cancelled Post Market | Glaxosmithkline Inc | Jan 2024 |
| DOM-AMOXICILLIN (250 MG)Dominion Pharmacal · Status since May 2025 | 02230615 | Cancelled Pre Market | Dominion Pharmacal | May 2025 |
| DOM-AMOXICILLIN (500 MG)Dominion Pharmacal · Status since May 2025 | 02230616 | Cancelled Pre Market | Dominion Pharmacal | May 2025 |
| DOM-AMOXICILLIN (125 MG)Dominion Pharmacal · Status since May 2025 | 02230617 | Cancelled Pre Market | Dominion Pharmacal | May 2025 |
| DOM-AMOXICILLIN (250 MG)Dominion Pharmacal · Status since May 2025 | 02230618 | Cancelled Pre Market | Dominion Pharmacal | May 2025 |
| HP-PAC (500 MG)Takeda Pharmaceuticals America Inc · Status since Mar 2021 | 02238525 | Cancelled Post Market | Takeda Pharmaceuticals America Inc | Mar 2021 |
| LIN-AMOX - CAP 250MG (250 MG)Linson Pharma Co. · Status since May 2006 | 02181487 | Cancelled Post Market | Linson Pharma Co. | May 2006 |
| LIN-AMOX - CAP 500MG (500 MG)Linson Pharma Co. · Status since May 2006 | 02181495 | Cancelled Post Market | Linson Pharma Co. | May 2006 |
| LIN-AMOX - PWS 125MG/5ML (125 MG)Linson Pharma Co. · Status since May 2006 | 02181509 | Cancelled Post Market | Linson Pharma Co. | May 2006 |
| LIN-AMOX - PWS 250MG/5ML (250 MG)Linson Pharma Co. · Status since May 2006 | 02181517 | Cancelled Post Market | Linson Pharma Co. | May 2006 |
| MYLAN-AMOXICILLIN (250 MG)Mylan Pharmaceuticals Ulc · Status since Jul 2018 | 02238171 | Cancelled Post Market | Mylan Pharmaceuticals Ulc | Jul 2018 |
| MYLAN-AMOXICILLIN (500 MG)Mylan Pharmaceuticals Ulc · Status since Sep 2019 | 02238172 | Cancelled Post Market | Mylan Pharmaceuticals Ulc | Sep 2019 |
| NOROCLAV (50 MG)Norbrook Laboratories Ltd. · Status since Nov 2018 | 02323850 | Cancelled Post Market | Norbrook Laboratories Ltd. | Nov 2018 |
| NOROCLAV (100 MG)Norbrook Laboratories Ltd. · Status since Nov 2018 | 02323869 | Cancelled Post Market | Norbrook Laboratories Ltd. | Nov 2018 |
| NOROCLAV (200 MG)Norbrook Laboratories Ltd. · Status since Nov 2018 | 02323877 | Cancelled Post Market | Norbrook Laboratories Ltd. | Nov 2018 |
| NOROCLAV (300 MG)Norbrook Laboratories Ltd. · Status since Nov 2018 | 02323893 | Cancelled Post Market | Norbrook Laboratories Ltd. | Nov 2018 |
| NOVAMOXIN (125 MG)Teva Canada Limited · Status since Jul 2021 | 00452149 | Cancelled Post Market | Teva Canada Limited | Jul 2021 |
| NOVAMOXIN (125 MG)Teva Canada Limited · Status since Jul 2021 | 02036347 | Cancelled Post Market | Teva Canada Limited | Jul 2021 |
| NOVAMOXIN (125 MG)Teva Canada Limited · Status since Jul 2021 | 01934171 | Cancelled Post Market | Teva Canada Limited | Jul 2021 |
| NOVO-CLAVAMOXIN 125 (125 MG)Novopharm Limited · Status since Oct 2015 | 02245206 | Cancelled Pre Market | Novopharm Limited | Oct 2015 |
| NOVO-CLAVAMOXIN 250 (250 MG)Novopharm Limited · Status since Oct 2015 | 02245207 | Cancelled Pre Market | Novopharm Limited | Oct 2015 |
| NOVO-CLAVAMOXIN 875 (875 MG)Novopharm Limited · Status since Oct 2015 | 02248138 | Cancelled Post Market | Novopharm Limited | Oct 2015 |
| NTP-AMOXICILLIN (250 MG)Teva Canada Limited · Status since Aug 2015 | 02345501 | Cancelled Pre Market | Teva Canada Limited | Aug 2015 |
| NTP-AMOXICILLIN (500 MG)Teva Canada Limited · Status since Aug 2015 | 02345528 | Cancelled Pre Market | Teva Canada Limited | Aug 2015 |
| NTP-AMOXICILLIN (250 MG)Teva Canada Limited · Status since Aug 2015 | 02345536 | Cancelled Pre Market | Teva Canada Limited | Aug 2015 |
| NTP-AMOXICILLIN (125 MG)Teva Canada Limited · Status since Aug 2015 | 02345544 | Cancelled Pre Market | Teva Canada Limited | Aug 2015 |
| NTP-AMOXICILLIN (250 MG)Teva Canada Limited · Status since Aug 2015 | 02345552 | Cancelled Pre Market | Teva Canada Limited | Aug 2015 |
| NTP-AMOXICILLIN (125 MG)Teva Canada Limited · Status since Aug 2015 | 02348012 | Cancelled Pre Market | Teva Canada Limited | Aug 2015 |
| NTP-AMOXICILLIN (250 MG)Teva Canada Limited · Status since Aug 2015 | 02348020 | Cancelled Pre Market | Teva Canada Limited | Aug 2015 |
| NU-AMOXI CAP 250MG (250 MG)Nu-Pharm Inc · Status since Sep 2012 | 00865567 | Cancelled Post Market | Nu-Pharm Inc | Sep 2012 |
| NU-AMOXI CAP 500MG (500 MG)Nu-Pharm Inc · Status since Sep 2012 | 00865575 | Cancelled Post Market | Nu-Pharm Inc | Sep 2012 |
| NU-AMOXI SUS 125/5ML (125 MG)Nu-Pharm Inc · Status since Sep 2012 | 00865540 | Cancelled Post Market | Nu-Pharm Inc | Sep 2012 |
| NU-AMOXI SUS 250MG/5ML (250 MG)Nu-Pharm Inc · Status since Sep 2012 | 00865559 | Cancelled Post Market | Nu-Pharm Inc | Sep 2012 |
| PENTA-AMOXICILLIN (500 MG)Pentapharm Ltd. · Status since Apr 2018 | 02233017 | Cancelled (Unreturned Annual) | Pentapharm Ltd. | Apr 2018 |
| PENTA-AMOXICILLIN - 125MG/5ML (125 MG)Pentapharm Ltd. · Status since Apr 2018 | 02229582 | Cancelled (Unreturned Annual) | Pentapharm Ltd. | Apr 2018 |
| PENTA-AMOXICILLIN - 250MG CAPSULES (250 MG)Pentapharm Ltd. · Status since Apr 2018 | 02229584 | Cancelled (Unreturned Annual) | Pentapharm Ltd. | Apr 2018 |
| PENTA-AMOXICILLIN - 250MG/5ML (250 MG)Pentapharm Ltd. · Status since Apr 2018 | 02229583 | Cancelled (Unreturned Annual) | Pentapharm Ltd. | Apr 2018 |
| PHL-AMOXICILLIN (250 MG)Pharmel Inc. · Status since Mar 2005 | 02262851 | Cancelled Post Market | Pharmel Inc. | Mar 2005 |
| PHL-AMOXICILLIN (500 MG)Pharmel Inc. · Status since Mar 2005 | 02262878 | Cancelled Post Market | Pharmel Inc. | Mar 2005 |
| PHL-AMOXICILLIN (125 MG)Pharmel Inc. · Status since Mar 2005 | 02262886 | Cancelled Post Market | Pharmel Inc. | Mar 2005 |
| PHL-AMOXICILLIN (250 MG)Pharmel Inc. · Status since Mar 2005 | 02262894 | Cancelled Post Market | Pharmel Inc. | Mar 2005 |
| PHL-AMOXICILLIN (125 MG)Pharmel Inc. · Status since Sep 2017 | 02351153 | Cancelled Pre Market | Pharmel Inc. | Sep 2017 |
| PHL-AMOXICILLIN (250 MG)Pharmel Inc. · Status since Sep 2017 | 02351161 | Cancelled Pre Market | Pharmel Inc. | Sep 2017 |
| PHL-AMOXICILLIN (250 MG)Pharmel Inc. · Status since Sep 2017 | 02351188 | Cancelled Pre Market | Pharmel Inc. | Sep 2017 |
| PHL-AMOXICILLIN (500 MG)Pharmel Inc. · Status since Sep 2017 | 02351196 | Cancelled Pre Market | Pharmel Inc. | Sep 2017 |
| PMS-AMCLAV-200 (200 MG)Pharmascience Inc. · Status since Aug 2017 | 02241001 | Cancelled Pre Market | Pharmascience Inc. | Aug 2017 |
| PMS-AMCLAV-400 (400 MG)Pharmascience Inc. · Status since Aug 2017 | 02241000 | Cancelled Pre Market | Pharmascience Inc. | Aug 2017 |
| PMS-AMCLAV-875 (875 MG)Pharmascience Inc. · Status since Aug 2017 | 02240999 | Cancelled Pre Market | Pharmascience Inc. | Aug 2017 |
| PMS-AMOXICILLIN (250 MG)Pharmascience Inc. · Status since Apr 2025 | 02230243 | Cancelled Post Market | Pharmascience Inc. | Apr 2025 |
| PMS-AMOXICILLIN (500 MG)Pharmascience Inc. · Status since Apr 2025 | 02230244 | Cancelled Post Market | Pharmascience Inc. | Apr 2025 |
| PMS-AMOXICILLIN (125 MG)Pharmascience Inc. · Status since Apr 2025 | 02230245 | Cancelled Post Market | Pharmascience Inc. | Apr 2025 |
| PMS-AMOXICILLIN (250 MG)Pharmascience Inc. · Status since Apr 2025 | 02230246 | Cancelled Post Market | Pharmascience Inc. | Apr 2025 |
| PRO AMOX PWR FOR ORAL SUSP 125MG/5ML (125 MG)Pro Doc Limitee · Status since Jul 2009 | 00644323 | Cancelled Post Market | Pro Doc Limitee | Jul 2009 |
| PRO AMOX-250 CAP 250MG (250 MG)Pro Doc Limitee · Status since Jul 2010 | 00644307 | Cancelled Post Market | Pro Doc Limitee | Jul 2010 |
| RATIO-ACLAVULANATE (250 MG)Ratiopharm Inc Division Of Teva Canada Limited · Status since Jul 2009 | 02243770 | Cancelled Post Market | Ratiopharm Inc Division Of Teva Canada Limited | Jul 2009 |
| RATIO-ACLAVULANATE (500 MG)Teva Canada Limited · Status since May 2018 | 02243771 | Cancelled Post Market | Teva Canada Limited | May 2018 |
| RATIO-ACLAVULANATE (875 MG)Teva Canada Limited · Status since May 2018 | 02247021 | Cancelled Post Market | Teva Canada Limited | May 2018 |
| RATIO-ACLAVULANATE 125 F (125 MG)Teva Canada Limited · Status since May 2018 | 02244646 | Cancelled Post Market | Teva Canada Limited | May 2018 |
| RATIO-ACLAVULANATE 250 F (250 MG)Teva Canada Limited · Status since May 2018 | 02244647 | Cancelled Post Market | Teva Canada Limited | May 2018 |
| RIVA-AMOXICILLIN 125MG/5ML FOR ORAL SUSPENSION (125 MG)Laboratoire Riva Inc. · Status since Jul 2003 | 02240829 | Cancelled Post Market | Laboratoire Riva Inc. | Jul 2003 |
| RIVA-AMOXICILLIN 250MG/5ML FOR ORAL SUSPENSION (250 MG)Laboratoire Riva Inc. · Status since Jul 2003 | 02240830 | Cancelled Post Market | Laboratoire Riva Inc. | Jul 2003 |
| SANDOZ AMOXICILLIN (250 MG)Sandoz Canada Inc. · Status since Mar 2021 | 02474751 | Cancelled Pre Market | Sandoz Canada Inc. | Mar 2021 |
| SANDOZ AMOXICILLIN (500 MG)Sandoz Canada Inc. · Status since Mar 2021 | 02474778 | Cancelled Pre Market | Sandoz Canada Inc. | Mar 2021 |
| VETOMOXIN 100 (100 MG)Vetoquinol N A Inc · Status since Mar 2017 | 02320584 | Cancelled Pre Market | Vetoquinol N A Inc | Mar 2017 |
| VETOMOXIN 20 (20 MG)Vetoquinol N A Inc · Status since Mar 2017 | 02320576 | Cancelled Pre Market | Vetoquinol N A Inc | Mar 2017 |